Quantifying Antibody Persistence After a Single Dose of <scp>COVID</scp> ‐19 Vaccine Ad26. <scp>COV2</scp> .S in Humans Using a Mechanistic Modeling and Simulation Approach-Reference-Cited by-同舟云学术

Quantifying Antibody Persistence After a Single Dose of COVID ‐19 Vaccine Ad26. COV2 .S in Humans Using a Mechanistic Modeling and Simulation Approach

Published:2022-12-09 Issue:2 Volume:113 Page:380-389
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Dari Anna¹,Boulton Muriel¹^ORCID,Neyens Martine¹,Le Gars Mathieu²,Valenzuela Belén³^ORCID,Shukarev Georgi²^ORCID,Cárdenas Vicky⁴,Ruiz‐Guiñazú Javier¹^ORCID,Sadoff Jerald²,Hoetelmans Richard M. W.¹^ORCID,Ruixo Juan José Pérez¹^ORCID

Affiliation:

1. Janssen Research and Development Beerse Belgium

2. Janssen Vaccines and Prevention Leiden The Netherlands

3. Janssen‐Cilag Spain Part of Janssen Pharmaceutical Companies Madrid Spain

4. Janssen Research and Development Spring House Pennsylvania USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2796

Reference45 articles.

1. Mechanisms of SARS-CoV-2 Transmission and Pathogenesis

2. COVID-19 therapeutics: Challenges and directions for the future

3. World Health Organization (WHO).Interim statement on the use of additional booster doses of Emergency Use Listed mRNA vaccines against COVID‐19 (May 2022). Accessed June 13 2022.

4. Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses

5. Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Pharmacology Perspective on Development of Adeno‐Associated Virus Vector‐Based Retina Gene Therapy;Clinical Pharmacology & Therapeutics;2024-03-07

2. Mechanistic modeling projections of antibody persistence after homologous booster regimens of COVID‐19 vaccine Ad26.COV2.S in humans;CPT: Pharmacometrics & Systems Pharmacology;2023-09-15

3. Mechanistic Model Describing the Time Course of Humoral Immunity Following Ad26.COV2.S Vaccination in Non-Human Primates;Journal of Pharmacology and Experimental Therapeutics;2023-08-03

4. Quantitative mechanistic model reveals key determinants of placental IgG transfer and informs prenatal immunization strategies;2023-04-18